Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Spindletop Health Acquisition Corp.SCHAU · Entity 133576 | Chief Operating Officer | November 03, 2021 | November 03, 2021 |
| Vyome Holdings, IncOBLN · Entity 1824 | Director · Pres & Chief Executive Officer | January 02, 2019 | January 04, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Spindletop Health Acquisition Corp.
Report date November 03, 2021 · Filed November 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-11-03 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination or earlier at the option of the holder as described under the heading "Description of Securities--Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-254531), on a one-for-one basis, subject to adjustment for stock splits, stock capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination or earlier at the option of the holder as described under the heading "Description of Securities--Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-254531), on a one-for-one basis, subject to adjustment for stock splits, stock capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
Vyome Holdings, Inc
Report date January 02, 2019 · Filed January 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.30 · Expires 2029-01-02 | Direct | 300,000 |
Reported balance
After 2019-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-01-02 · Grant · Acquired 300,000 · Balance 300,000 F1: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2019 Filed Jan 4, 2019 23:30 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001214659-19-000149 · marketforms-43639.xml · derivative · entry 1 Huang Kelly · CIK 0001602803 · Director · Pres & Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. Read SEC document |
| August 23, 2018 Filed Aug 28, 2018 01:34 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock | 54,945 | $1.82 | $99,999.90 |
DisclosureSEC source: 0001214659-18-005742 · marketforms-42785.xml · nonDerivative · entry 1 Huang Kelly · CIK 0001602803 · Pres & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,945 F1 · shares: The reporting person purchased these shares directly from the issuer in a private placement. F2 · balance_after: Includes Restricted Shares that are subject to vesting. Read SEC document |
| May 15, 2018 Filed May 17, 2018 23:19 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantCommon Stock (Restricted Stock Award) | 65,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-003874 · marketforms-42030.xml · nonDerivative · entry 1 Huang Kelly · CIK 0001602803 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 F1 · shares: The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:12 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001214659-18-000187 · marketforms-40641.xml · derivative · entry 1 Huang Kelly · CIK 0001602803 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2028-01-02 F1 · derivative.exercise_date: The Option shall vest as to 1/6th of the Shares underlying the Option on September 6, 2018 (i.e., the one-year anniversary of Mr. Huang's employment commencement date) and as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date thereafter, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date. In addition, any portion of the Option that vests prior to the date on which Mr. Huang relocates his primary residence in accordance with the Relocation Obligations (as defined in his employee offer letter agreement with the Company dated September 6, 2017) will not be exercisable until such relocation date. The Option will automatically expire if Mr. Huang does not satisfy the Relocation Obligations. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 20:49 UTC | Vyome Holdings, Inc OBLN · Entity 1824 | GrantStock Option (Right to Buy) · Derivative | 269,230 | $0.00 Strike: $9.31 | $0.00 |
DisclosureSEC source: 0001214659-17-005564 · marketforms-39586.xml · derivative · entry 1 Huang Kelly · CIK 0001602803 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,230 Underlying: Common Stock · 269,230 shares Expires 2027-09-05 F1 · derivative.exercise_date: This option vests as to 25% of the total shares on September 6, 2018, then 2.083% monthly, with 100% of the total shares vested on September 6, 2021, subject to the reporting person's provision of service to the Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.